Page last updated: 2024-10-30

mesalamine and Cholelithiasis

mesalamine has been researched along with Cholelithiasis in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Cholelithiasis: Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).

Research Excerpts

ExcerptRelevanceReference
"The risk of acute pancreatitis in patients with IBD is increased due to the higher incidence of cholelithiasis and drug-induced pancreatitis in this population."2.82Pancreatic Disorders in Patients with Inflammatory Bowel Disease. ( Bi, Y; Corral, JE; Farraye, FA; Ji, B; Kröner, PT; Lukens, FJ; Montenegro, ML, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Montenegro, ML1
Corral, JE1
Lukens, FJ1
Ji, B1
Kröner, PT1
Farraye, FA1
Bi, Y1
Bernstein, CN1

Reviews

1 review available for mesalamine and Cholelithiasis

ArticleYear
Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
    Digestive diseases and sciences, 2022, Volume: 67, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Pancreatitis; Azathioprin

2022

Other Studies

1 other study available for mesalamine and Cholelithiasis

ArticleYear
Placebos in medicine.
    Seminars in gastrointestinal disease, 1999, Volume: 10, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholelithiasis; Clinical Trials as Topic; Colitis, U

1999